Journal Article10.1111/j.1610-0387.2007.06450_supp.x
Kutane Lymphome
R. Dummer,Rudolf Stadler,W. Sterry +2 more
- 01 Jul 2007
Vol. 5
TL;DR: Kutane Lymphome sind seltene Hauterkrankungen, die eine günstige Prognose mit chronischem Verlauf haben.
read more
Abstract: Zusammenfassung Kutane Lymphome sind seltene Hauterkrankungen. Sie sind von sekundären Hautinfiltraten bei primär nodalen Lymphomen abzugrenzen. Die primären kutanen Lymphome können in Bund T-Zell-Lymphome und hämatodermische Erkrankungen unterteilt werden, sie weisen meist eine insgesamt günstige Prognose mit chronischem Verlauf auf. Die Therapie ist stadienabhängig. Da eine Heilung nicht möglich ist, gilt es, den Krankheitsverlauf unter Kontrolle zu halten und die Symptome zu lindern. Seit einigen Jahren werden zahlreiche neue Medikamente für diese Erkrankungen entwickelt.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
References
WHO-EORTC classification for cutaneous lymphomas.
Rein Willemze,Elaine S. Jaffe,Günter Burg,Lorenzo Cerroni,Emilio Berti,Steven H. Swerdlow,Elisabeth Ralfkiaer,Sergio Chimenti,José Luis Diaz-Perez,Lyn M. Duncan,Florent Grange,Nancy L. Harris,Werner Kempf,Helmut Kerl,Michael O. Kurrer,Robert Knobler,Nicola Pimpinelli,Chris Sander,Marco Santucci,Wolfram Sterry,Maarten H. Vermeer,Janine Wechsler,Sean Whittaker,Chris J.L.M. Meijer +23 more
TL;DR: The characteristic features of the different primary cutaneous lymphomas and other hematologic neoplasms frequently presenting in the skin are described, and differences with the previous classification schemes are discussed.
3.8K
A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.
Frederic J. Kaye,Paul A. Bunn,Seth M. Steinberg,J L Stocker,Daniel C. Ihde,A. B. Fischmann,Eli Glatstein,Geraldine P. Schechter,Ruby Phelps,Francine M. Foss +9 more
TL;DR: It is concluded that early aggressive therapy with radiation and chemotherapy does not improve the prognosis for patients with mycosis fungoides as compared with conservative treatment beginning with sequential topical therapies.
501
Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.
Eric C. Vonderheid,Maria Grazia Bernengo,Günter Burg,Madeleine Duvic,Peter Heald,Liliane Laroche,Elise A. Olsen,Mark R. Pittelkow,Robin Russell-Jones,Masahiro Takigawa,Rein Willemze +10 more
TL;DR: The hematologic criteria recommended for Sézary syndrome are intended to identify patients with a worse prognosis compared with the other E-CTCL subsets and consist of one or more of the following: an absolute SéZary cell count and a CD4/CD8 ratio of 10 or higher.
495
Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior
Emilio Berti,Dario Tomasini,Maarten H. Vermeer,Chris J.L.M. Meijer,Elvio Alessi,Rein Willemze +5 more
TL;DR: In this article, the clinical, histological, and immunophenotypical features of 17 CD8+ CTCL were reviewed, and the results indicated that these strongly epidermotropic primary cutaneous CD8+, cytotoxic T cell lymphomas represent a distinct type of CTCCL with an aggressive clinical behavior.
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
Franz Trautinger,Robert Knobler,Rein Willemze,Ketty Peris,Rudolph Stadler,Liliane Laroche,Michel D'Incan,Annamari Ranki,Nicola Pimpinelli,Pablo L. Ortiz-Romero,Reinhard Dummer,Teresa Estrach,Sean Whittaker +12 more
TL;DR: Skin-directed therapies are the most appropriate option for early-stage MF/SS and most patients can look forward to a normal life expectancy.
427